FGFR1-amplification, predominantly found in squamous cell lung carcinoma, is currently an inclusion criterion in a clinical randomized phase I/II study of AZD4547 (NCT01824901). The gene discussed is FGFR1; the disease is squamous cell lung carcinoma.